About Us

Cloud and edge smell computing from Austin, Texas

NEUVALAB, based in Austin, Texas, is dedicated to delivering genuine, forward-thinking solutions for cloud and edge smell computing, air-quality intelligence, and continuous environmental monitoring. We are building a new generation of intelligent sensing systems that transform invisible indoor air signals into meaningful insights. By combining advanced VOC and gas sensing, embedded edge processing, cloud connectivity, and AI-driven analytics, NEUVALAB enables spaces to be monitored continuously for odor patterns, harmful gases, abnormal air conditions, and early indicators that may relate to health, comfort, safety, or operational risk.

Our technology is designed for environments where air tells a story: homes, bathrooms, bedrooms, healthcare facilities, elderly-care spaces, workplaces, factories, laboratories, hospitality spaces, and industrial sites. NEUVALAB devices capture environmental signals at the edge, transmit them securely to the cloud, and allow our AI backend to analyze trends, detect anomalies, and identify complex patterns that traditional sensors alone cannot interpret.

At the heart of NEUVALAB is a high-level AI architecture powered by deep learning, time-series analysis, advanced data servers, and cloud-based AI networks. This enables continuous improvement as more environmental data is collected, processed, and understood. The result is a smarter monitoring platform capable of supporting medical, consumer, and industrial applications with scalable intelligence.

We believe the future of smell computing will go far beyond simple detection. It will become an intelligent layer of connected environments, where cloud AI, edge devices, and advanced sensor networks work together to identify risks, improve wellbeing, optimize operations, and provide actionable insights in real time. NEUVALAB is developing this future: intelligent, connected, continuous, and deeply data-driven.

Austin, Texas
What we solve?

AI cloud for odor intelligence and artificial olfaction

NEUVALAB is an AI cloud platform for odor intelligence and artificial olfaction targeting VOC analysis, and early disease-related signal detection.

We combine smart edge sensing devices, continuous air monitoring, edge processing, and cloud-based deep learning to detect abnormal odor, gas, and VOC patterns in real time.

Early disease-related signal detection
Analyze VOC patterns from breath, urine, skin, and indoor environments.
Continuous non-invasive monitoring
Detect machine emissions, process instability, leaks, and abnormal conditions.
Healthier homes and products
Monitor air quality, freshness, odor events, and comfort signals.
Why Scent Matters

Invisible air signatures can tell a story

Medical environment

Medical / Healthcare

Many diseases emit volatile biomarkers. NEUVALAB uses continuous VOC sensing and AI pattern recognition to help detect abnormal signals early.

Industrial plant

Industrial

Machines emit VOCs and gas signatures that can reveal overheating, leaks, contamination, wear or process instability before failure.

Smart home environment

Consumer

Consumers want safer, cleaner and healthier indoor environments. Smart odor intelligence supports better living spaces.

System Architecture

NEUVALAB AI Scent Analyzer

Smell sensor time series are transmitted to the NEUVALAB cloud where AI analysis identifies odor signatures and abnormal patterns.

NEUVALAB system architecture
SM-100 odor intelligence device with blue sensing waves
Devices

SM-100 AI-Powered Odor Intelligence for Disease Detection

Neuvalab leverages advanced AI and sensor technology to analyze bathroom-derived odor signatures, transforming everyday environments into powerful, non-invasive health monitoring points.

By capturing and processing volatile organic compounds (VOCs), the system securely transmits data to the cloud, where intelligent models identify patterns associated with a wide range of conditions including metabolic, inflammatory, intestinal, and genetic disorders.

Prostate Cancer Detection

Brief Insight

Prostate cancer, one of the most common cancers in men, is often associated with subtle biochemical changes in the body. These changes can alter the composition of VOCs released through urine.

Research has shown that specific VOC patterns—linked to tumor metabolism and oxidative stress—can be detected through odor analysis. Advanced sensor arrays (e-noses), combined with AI, can recognize these signatures with increasing accuracy, enabling:

  • Early, non-invasive screening
  • Continuous monitoring without clinical visits
  • Potential pre-symptomatic detection

Neuvalab’s platform aims to bring this capability into daily life, offering a discreet, scalable, and preventive healthcare solution.

Prostate cancer awareness
Applications

Focused application sectors

Each application is presented as a larger visual line so the presentation imagery stays visible and impactful.

Medical

Medical

Breath ScreeningInfection DetectionDisease DetectionRemote Patient Diagnostics
Healthcare

Healthcare

Smart Home Air QualityPersonal Wellness InsightsRooms Freshness Alerts & PetsWearables & Lifestyle Tech
Food and Beverage

Food & Beverage

Coffee RoastingWine CompositionCooking & CompositionsF&V Freshness
Industrial

Industrial

Gas Leaks & SafetyPredictive MaintenanceEnvironmental ComplianceMaterial Inspection
Smart Environment and Storage

Smart Environment & Storage Monitoring

Agriculture & Crop HealthGrain Silos & Storage FacilitiesLivestock & Animal EnvironmentsWaste, Compost & Bio-Processing
Scent Intelligence

Scent Intelligence & Experience

Fragrance Profiling & AnalysisConsumer ExperienceBrand Signature ScentingDigital Olfaction & Scent
Our Team

Leadership

Pierre ToumaPierre TOUMAChief Executive Officer
pierre.touma@neuvalab.com
Joe HageJoe HAGEChief Operating Officer
joe.hage@neuvalab.com
Abir HosriAbir HOSRIVP Artificial Intelligence
abir.hosri@neuvalab.com
Imad MaaloufImad MAALOUFVP Hardware Design
imad.maaloouf@neuvalab.com
Elias BachaalanyElias BACHAALANYVP Technology
elias.bachaalany@neuvalab.com